Results 181 to 190 of about 102,229 (258)

Effect of phosphodiesterase inhibitors on platelet function. [PDF]

Biochem Biophys Rep
Hochuli R, Dicenta V, Laspa Z, Sigle M, Harm T, Castor T, Rohlfing AK, Gawaz MP.   +7 more
europepmc   +1 more source

A cAMP-Specific Phosphodiesterase Inhibitor Preserves the Motility of Washed Human Sperm

, 1997
J Fisch
openalex   +1 more source

Phosphodiesterase 1A physically interacts with YTHDF2 and reinforces the progression of non-small cell lung cancer. [PDF]

Elife
Zhang C, Zhang Z, Wu Y, Wu Y, Cheng J, Luo K, Li Z, Zhang M, Wang J, Zhang X, Li Y.   +10 more
europepmc   +1 more source

Antiplatelet and cardiovascular effects of NM-702, a novel multiple inhibitor of cyclic-nudeotide phosphodiesterases and thromboxane A synthase.

, 1996
Nohutomo Tsuruzoe, Norimasa Shudo, Kanako Takahashi, Naoki Fujikura, Masakuni Nishikawa, Takeshi Uchida, Sakuya Tanaka   +6 more
openalex   +1 more source

Notes on Three Palustrine Natural Community Types in the Arkansas Ozarks [PDF]

, 1985
Orzell, Steve L., Pell, William F., Tucker, Gary E.   +2 more
core   +2 more sources

Factors associated with erectile dysfunction in men with lower urinary tract symptoms (LUTS): a Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) study. [PDF]

Transl Androl Urol
Boehm D, Smith AR, Mansfield SA, Flynn KE, Fantus RJ, Glaser AP, Helfand BT, Helmuth M, Morgan TN, Lai HH, Sarma AV, Yang CC, Kirkali Z, Griffith JW.   +13 more
europepmc   +1 more source

Effectiveness and safety of topical phosphodiesterase 4 inhibitors in children with mild-to-moderate atopic dermatitis: A systematic review and meta-analysis. [PDF]

J Int Med Res
Wang L, Zeng L, Wu Y, Zhong M, Zhang L, Li C.   +5 more
europepmc   +1 more source

Predicting Response to Switching From Phosphodiesterase Type 5 Inhibitor to Riociguat in Patients With Pulmonary Arterial Hypertension: Biomarker and Responder Analysis of the RESPITE and REPLACE Studies. [PDF]

Pulm Circ
Klinger JR, Al-Hiti H, Chang SA, Chang HJ, Ghofrani HA, Grünig E, Hoeper MM, Jansa P, Ota-Arakaki J, Pulido T, Simonneau G, Vizza CD, Rahner C, Meier C, Meyer G.   +14 more
europepmc   +1 more source

A phase 2 randomized, placebo-controlled study on the efficacy and safety of AR1001, a phosphodiesterase-5 inhibitor, in patients with mild-to-moderate Alzheimer's disease. [PDF]

J Prev Alzheimers Dis
Greeley D, Nash M, Herskowitz B, Kim F, Rock J, Prins N, Kim S, Xi T, Busam JA, Tete B, Choung JJ, Sha SJ.   +11 more
europepmc   +1 more source

An LC-MS/MS Assay of Irsenontrine, a Novel Phosphodiesterase‑9 Inhibitor, in Human Plasma, Urine and Cerebrospinal Fluid for Application to Clinical Pharmacokinetic Studies. [PDF]

ACS Omega
Hotta K, Doda K, Aluri J, Mano Y.
europepmc   +1 more source